SPA
ROIV icon

Sherbrooke Park Advisers’s Roivant Sciences ROIV Stock Holding History

Sherbrooke Park Advisers’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,634
Closed -$221K – 477
2025
Q3 		$221K Buy
+14,634
New +$181K 0.1% 356

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Sherbrooke Park Advisers's ROIV Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of Roivant Sciences (ROIV) in Q4 2025, closing a stake of 14,634 shares — an estimated $221K sold.

Sherbrooke Park Advisers first reported a position in ROIV in Q3 2025 and held it in 1 quarter. The position peaked at $221K in Q3 2025. 398 funds tracked by Wall St. Rank hold ROIV as of Q4 2025.

  • Sherbrooke Park Advisers reported no remaining Roivant Sciences position as of Q4 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 14,634 Roivant Sciences shares in Q4 2025, an estimated $221K.
  • Sherbrooke Park Advisers first reported a position in Roivant Sciences in Q3 2025 and held it in 1 quarter.
  • Sherbrooke Park Advisers's Roivant Sciences position peaked at $221K in Q3 2025.
  • 398 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.